Guest Blogs - Express Pharma

The algorithmic inversion of pharma

India’s upcoming semaglutide boom: A turning point for GLP‑1 drugs, pricing and patient access

Invisible but indispensable: Why high purity & premium grade refined Naphthalene is critical to Indian pharma

Redrawing the biopharma map: India’s rise in the biosimilars era

You do not need to become someone else to lead

How inclusive leadership drives better health outcomes for women

To all women in pharma, current and future leaders

India’s pharma industry trails behind: The digital validation technology gap

Glass vs other pharma packaging materials: Safeguarding purity, enhancing trust

When companies break bad: Directors’ liability under Drugs and Cosmetics Act, 1940